These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 6152613)

  • 1. Multiple opioid receptor systems in brain and spinal cord: Part I.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Jun; 1(2):171-99. PubMed ID: 6152613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endorphins, opioid receptors and site of action of morphinomimetics].
    Cesselin F
    Agressologie; 1991; 32(6-7):310-7. PubMed ID: 1688219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple opiate receptors and their functional significance.
    Herz A
    J Neural Transm Suppl; 1983; 18():227-33. PubMed ID: 6135743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
    Giordano AL; Nock B; Cicero TJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):536-40. PubMed ID: 2173747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid peptide receptors and membrane biology.
    Smith AP; Loh HH
    Prog Clin Biol Res; 1982; 97():113-35. PubMed ID: 6296876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain.
    Nock B; Giordano AL; Moore BW; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):349-59. PubMed ID: 8380865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

  • 13. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents.
    Stevens CW
    Cancer Surv; 1994; 21():25-47. PubMed ID: 8564997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opioid receptors and their selective ligands].
    Piestrzeniewicz MK; Fichna J; Janecka A
    Postepy Biochem; 2006; 52(3):313-9. PubMed ID: 17201067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple opioid receptors: ligand selectivity profiles and binding site signatures.
    Goldstein A; Naidu A
    Mol Pharmacol; 1989 Aug; 36(2):265-72. PubMed ID: 2549383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.